Clinerion’s Patient Network Explorer Adds Four New Hospitals in Brazil
Clinerion has extended its patient coverage in Brazil to four new hospitals with the help of partner iHealth Group. This raises the footprint of Clinerion’s Patient Network Explorer to 17 healthcare organizations and over 7 million patients.
The four newest Brazilian hospitals to join the global community of partner hospitals on Clinerion’s Patient Network Explorer platform are:
- Hospital São Lucas—PUCRS, Porto Alegre, Rio Grande do Sul
- Hospital Martagão Gesteira, Salvador, Bahia
- Hospital Ana Nery, Salvador, Bahia
- Centro Regional Integrado de Oncologia (CRIO), Fortaleza, Ceará
They are projected to go online in Patient Network Explorer by the end of May 2021. The hospital network in Brazil comprises hospitals of varied sizes, locations and specializations.
For more information, click here.
Final ENLIVEN Trial Results Confirm Long-Term Benefit of Turalio in Tenosynovial Giant Cell Tumor
July 9th 2025In final data from the Phase III ENLIVEN study, Turalio (pexidartinib) demonstrated durable tumor responses and a consistent safety profile in patients with symptomatic TGCT not amenable to surgery.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
FDA Expands Farapulse PFA Approval to Persistent AF After Strong ADVANTAGE AF Trial Results
July 7th 2025Boston Scientific’s Farapulse Pulsed Field Ablation System is now approved for treating persistent atrial fibrillation, following 12-month data from the ADVANTAGE AF trial showing strong safety, high freedom from AF, and no major complications.
Effect of AI/ML, Real World Evidence and Master Protocols on Trial Success
July 7th 2025How the application of artificial intelligence, broader use of real-world evidence, decentralized clinical trials, master protocols, and risk-based quality monitoring, together with strong ethical oversight and increased collaboration, are contributing to better healthcare delivery and strengthening the role of clinical research in driving global health progress.
